Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-γ coactivator-1α acetylation
Weijin Fang, Xiaomei Li, Xinke Zhou, Yan Xiong
Topics & Concepts
ResveratrolDiabetic cardiomyopathyAcetylationAsymmetric dimethylarginineEndocrinologyInternal medicineMitochondrial biogenesisMitochondrionSirtuin 1EndogenyPeroxisome proliferator-activated receptorCoactivatorChemistryBiologyReceptorCardiomyopathyPharmacologyMedicineBiochemistryArginineHeart failureDownregulation and upregulationTranscription factorGeneAmino acidSirtuins and Resveratrol in MedicineNitric Oxide and Endothelin EffectsCardiovascular Function and Risk Factors